![Dimitry Nuyten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dimitry Nuyten
Keine laufenden Positionen mehr
Profil
Dimitry S.
A. Nuyten formerly worked at Bristol Myers Squibb Co., as Group Medical Director from 2008 to 2013, Pfizer Inc., as Vice President from 2013 to 2019, Nektar Therapeutics, as Chief Medical Officer & Senior Vice President from 2021 to 2022, Aduro BioTech, Inc., as Chief Medical Officer, and Arcus Biosciences, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Nuyten received his doctorate degree from the University of Amsterdam and doctorate degree from the University of Groningen.
Ehemalige bekannte Positionen von Dimitry Nuyten
| Unternehmen | Position | Ende |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.01.2025 |
| NEKTAR THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
| PFIZER INC. | Corporate Officer/Principal | 01.03.2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2013 |
| CHINOOK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dimitry Nuyten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Wählen Sie MarketScreener 
